Ipca Laboratories (India) Financial Diagnostics

IPCALAB -- India Stock  

INR 753.10  24.10  3.31%

Ipca Laboratories Limited diagnostics interface makes it easy to digest most current publicly released information about Ipca Laboratories as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Ipca Laboratories price relationship with some important fundamental indicators such as market cap and management efficiency.

Ipca Laboratories Note

The book value of the company was currently reported as 213.04. The company has Price/Earnings To Growth (PEG) ratio of 1.03. Ipca Laboratories Limited recorded earning per share (EPS) of 18.97. This company last dividend was issued on 2018-08-02. The firm had 5:1 split on 2010-03-22. Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients for various therapeutic segments in India. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India. Ipca Laboratories operates under Drug Manufacturers - Specialty Generic classification in India and is traded on National Stock Exchange of India. It employs 5051 people. To learn more about IPCA LABORATORIES call the company at 91 22 6647 4747 or check out http://www.ipca.com.

Ipca Laboratories Limited Alerts

Latest headline from www.business-standard.com: Most IT shares rise

Ipca Laboratories Thematic Classifications

Drugs IdeaDrugs
Drug manufacturing and delivery
Healthcare IdeaHealthcare
USA Equities from Healthcare industry as classified by Fama & French

Market Capitalization

The company currently falls under 'Large-Cap' category with current market capitalization of 86.61 B.


The company has Profit Margin (PM) of 7.29 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 8.48 % which suggests for every 100 dollars of sales it generated a net operating income of 0.08.

Management Efficiency

Ipca Laboratories Limited has return on total asset (ROA) of 4.31 % which means that it generated profit of $4.31 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 9.31 % meaning that it generated $9.31 on every $100 dollars invested by stockholders.

Technical Drivers

Ipca Laboratories Limited retains Downside Deviation of 1.76, Market Risk Adjusted Performance of 4.55 and Risk Adjusted Performance of 0.547. Ipca Laboratories technical analysis makes it possible for you to employ historical prices and volume momentum with intention to determine a pattern that calculates the direction of the corporation future prices. In other words you can use this information to find out if the corporation will indeed mirror its model of historical price patterns or the prices will eventually revert. We found nineteen technical drivers for Ipca Laboratories Limited which can be compared to its competitors. Please check out Ipca Laboratories Limited Jensen Alpha, and the relationship between Coefficient Of Variation and Potential Upside to decide if Ipca Laboratories is priced fairly providing market reflects its last-minute price of 753.1 per share.

Ipca Laboratories Limited Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ipca Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ipca Laboratories Limited. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Ipca Laboratories Technical and Predictive Indicators

Ipca Laboratories Forecast Models

Did you try this?

Run Focused Opportunities Now


Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Focused Opportunities

Also Currentnly Active

Purchased over 20 shares of
2 days ago
Traded for 107.27
Purchased over 70 shares of
2 days ago
Traded for 35.345
Purchased over 20 shares of
2 days ago
Traded for 131.79
Please also check Risk vs Return Analysis. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.
Search macroaxis.com